John Dawber, vice president and general manager of Novo Nordisk Thailand, offers his first impressions of the Thai market since moving from Japan. Dawber explains the current challenges and areas for improvement in diabetes treatment in Thailand, how the most innovative Novo Nordisk products have propelled the affiliate forward in Thailand, and the close collaborations it has in place with local stakeholders.
Every generation of our insulin products is on the market in Thailand, from the oldest to the latest, premium, and innovative products
